Biomedical Engineering Reference
In-Depth Information
26. Kreyling W, Semmler-Behnke M, Möller W. Health implications of nanoparticles.
Journal of
Nanoparticle Research
. 2006;8(5):543-62.
27. Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles: Can
in vitro
assays accu-
rately forecast lung hazards following inhalation exposures?
Environmental Science & Technology
.
2009;43(20):7939-45. Epub 2009/11/20.
28. Dhawan A, Sharma V. Toxicity assessment of nanomaterials: Methods and challenges.
Analytical and
Bioanalytical Chemistry
. 2010;398(2):589-605. Epub 2010/07/24.
29. Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and
in vitro
studies: The need of the hour.
Toxicology and Applied Pharmacology
. 2012;258(2):151-65. Epub 2011/12/20.
30. National Research Council (US).
Toxicity Testing in the 21st Century: A Vision and a Strategy
. The
National Academies Press; 2007.
31. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to
assess engineered nanoparticle toxicity in a human cell line.
Toxicology and Applied Pharmacology
.
2009;234(2):222-35. Epub 2008/11/06.
32. Griffiths SM, Singh N, Jenkins GJ, Williams PM, Orbaek AW, Barron AR et al. Dextran coated ultrafine
superparamagnetic iron oxide nanoparticles: Compatibility with common fluorometric and colorimetric
dyes.
Analytical Chemistry
. 2011;83(10):3778-85. Epub 2011/04/08.
33. Karlsson HL. The comet assay in nanotoxicology research.
Analytical and Bioanalytical Chemistry
.
2010;398(2):651-66. Epub 2010/07/20.
34. Singh N, Manshian B, Jenkins GJ, Griffiths SM, Williams PM, Maffeis TG et al. NanoGenotoxicology:
The DNA damaging potential of engineered nanomaterials.
Biomaterials
. 2009;30(23-24):3891-914.
Epub 2009/05/12.
35. Lai ZW, Yan Y, Caruso F, Nice EC. Emerging techniques in proteomics for probing nano-bio interactions.
ACS Nano
. 2012;6(12):10438-48. Epub 2012/12/12.
36. Buford MC, Hamilton RF, Jr., Holian A. A comparison of dispersing media for various engineered carbon
nanoparticles.
Particle and Fibre Toxicology
. 2007;4:6. Epub 2007/07/28.
37. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: Comparing
in vitro
measurements to
in vivo
pulmonary toxicity profiles.
Toxicological Sciences: An Official Journal of the
Society of Toxicology
. 2007;97(1):163-80. Epub 2007/02/16.
38. Chen C, Xing G, Wang J, Zhao Y, Li B, Tang J et al. Multihydroxylated [Gd Antineoplastic activity of
high efficiency and low toxicity.
Nano Letters
2005;5(10):2050-7. Epub 2005/10/13.
39. Gonzalez L, Sanderson BJ, Kirsch-Volders M. Adaptations of the
in vitro
MN assay for the genotoxicity
assessment of nanomaterials.
Mutagenesis
. 2011;26(1):185-91. Epub 2010/12/18.
40. Sayes C, Ivanov I. Comparative study of predictive computational models for nanoparticle-induced cyto-
toxicity.
Risk Analysis: An official publication of the Society for Risk Analysis
. 2010;30(11):1723-34.
Epub 2010/06/22.
41. North M, Vulpe CD. Functional toxicogenomics: Mechanism-centered toxicology.
International Journal
of Molecular Sciences
. 2010;11(12):4796-813. Epub 2010/01/01.
42. Curtis J, Greenberg M, Kester J, Phillips S, Krieger G. Nanotechnology and nanotoxicology: A primer
for clinicians.
Toxicological Reviews
. 2006;25(4):245-60. Epub 2007/02/10.
43. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number
of ultrafine particles.
American Journal of Respiratory and Critical Care Medicine
. 1997;155(4):1376-83.
44. Kane AB, Hurt RH. Nanotoxicology: The asbestos analogy revisited.
Nature Nanotechnology
.
2008;3(7):378-9. Epub 2008/07/26.
45. Donaldson K, Stone V, Duffin R, Clouter A, Schins R, Borm P. The quartz hazard: Effects of surface
and matrix on inflammogenic activity.
Journal of Environmental Pathology, Toxicology and Oncology:
Official Organ of the International Society for Environmental Toxicology and Cancer
. 2001;20(Suppl
1):109-18. Epub 2001/09/26.
46. Alfaro-Moreno E, Nawrot TS, Nemmar A, Nemery B. Particulate matter in the environment: Pulmonary and
cardiovascular effects.
Current Opinion in Pulmonary Medicine
. 2007;13(2):98-106. Epub 2007/01/27.
47. Gillissen A, Gessner C, Hammerschmidt S, Hoheisel G, Wirtz H. [Health significance of inhaled par-
ticles].
Deutsche medizinische Wochenschrift
. 2006;131(12):639-44. Epub 2006/03/18. Gesundheitliche
Bedeutung inhalierter Staube.
48. Warheit DB, Reed KL, Delorme MP. Embracing a weight-of-evidence approach for establishing NOAELs
for nanoparticle inhalation toxicity studies.
Toxicologic Pathology
. 2012. Epub 2012/12/18.
49. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW et al. Comparing
inhaled ultrafine versus fine zinc oxide particles in healthy adults: A human inhalation study.
American
Journal of Respiratory and Critical Care Medicine
. 2005;171(10):1129-35.